SCHEMBL7145884

SCHEMBL7145884

CC(C)(C)OC(=O)Nc1cc(OC(C)(C)C)c(-c2ccc(F)cc2)cc1NC(=O)CC(=O)c1cccc(C#N)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNQ4 P56696 3/20 0.39
KCNQ5 Q9NR82 3/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GSK3B P49841 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
VNN1 O95497 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
EGLN2 Q96KS0 1/20 0.34
RORC P51449 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
DHODH Q02127 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140101 0.90 KCNQ4 (0.36) KCNQ4KCNQ5KDM4EALDH1A1GSK3B
SCHEMBL7145960 0.88 EGLN2 (0.36) KCNQ4KCNQ5KDM4EALDH1A1GSK3B
SCHEMBL5869010 0.87 KCNQ4 (0.45) KCNQ4KCNQ5KDM4EALDH1A1GSK3B
SCHEMBL7145193 0.85 CYP17A1 (0.37) KCNQ4KCNQ5KDM4EEGLN2
SCHEMBL7141522 0.84 ALDH1A1 (0.42) KCNQ4KCNQ5KDM4EALDH1A1GSK3B
SCHEMBL5868790 0.83 KCNQ4 (0.40) KCNQ4KCNQ5KDM4EALDH1A1GSK3B
SCHEMBL5869054 0.83 KCNQ4 (0.40) KCNQ4KCNQ5KDM4EALDH1A1GSK3B
SCHEMBL5868849 0.83 KCNQ4 (0.41) KCNQ4KCNQ5GSK3BSIRT2SIRT1
SCHEMBL7141324 0.83 MEN1 (0.38) ALDH1A1GSK3BSIRT2SIRT1CHRM3
SCHEMBL5868878 0.83 KCNQ4 (0.44) KCNQ4KCNQ5KDM4EALDH1A1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed